← Open Payments lookup

CECILLE GUMABON: Open Payments

NPI 1548707854 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,440 in 82 payments from 33 companies in 2025. Trend: 2023 $1,630 · 2024 $1,492 · 2025 $2,440

Food & beverage: $2,340Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.14$587
Gilead Sciences, Inc.6$302
AstraZeneca Pharmaceuticals LP8$178
Novartis Pharmaceuticals Corporation4$102
ABBVIE INC.4$100
Merck Sharp & Dohme LLC4$98
Regeneron Healthcare Solutions, Inc.3$87
Exelixis Inc.3$86
Daiichi Sankyo Inc.3$77
Bayer Healthcare Pharmaceuticals Inc.2$63

Products named: RYBREVANT, Trodelvy, CALQUENCE, LIBTAYO, CABOMETYX, KEYTRUDA, Nubeqa, Enhertu.

Industry payments across MD — which companies pay providers there.